A twice-yearly injection could revolutionise HIV prevention, but who gets access raises bigger questions.
A twice-yearly injection could revolutionise HIV prevention. But who gets access raises bigger questions about public money, pharmaceutical power, drug prices and shrinking global health funding. Al Jazeera’s Mikail Malik looks at the fight over access.
Extract — continue reading at the source.
Related stories
Pennsylvania confirms fifth measles-associated death as US outbreak grows
Video: Bangladesh Dengue deaths surpass 233 in deadly outbreak
The overlooked power of diet for improving your mental health
After failed execution, health workers say Tennessee's method flouts medical ethics
Midwife Patients Struggle With Postpartum Mental Health: Survey
How empty chairs are helping people's mental health